National finalists for the 61st Australian Export Awards in the International Health category.
Avance Clinical is a full-service Contract Research Organisation for biotechs with a proven track-record for delivering clinical excellence in Australia, New Zealand and North America. Avance specializes in delivering top-tier clinical trials that yield globally accepted data. Avance is headquartered in Adelaide and has a footprint in the USA, India, Australia and New Zealand.
Avance currently employs over 300 staff. It is backed by the private equity group, Riverside Company, to support global expansion plans. The company uses state-of-the-art technology and systems to provide clients with the most effective processes. Avance’s export markets span North America, Asia, Europe and UK.
Visit Avance Clinical CRO website.
Better Breathing Sport makes a device that helps athletes and children improve their breathing, stamina and lung health.
The oscillating positive expiratory pressure device uses a natural process that mimics 15 to 35 mini coughs through resistance and vibration. This helps optimise lung capacity, improve lung clearance and increase oxygen delivery.
The device has been demonstrated around the world in the last 12 months, gaining attention from physiotherapists and sporting groups. The devices are sold in more 30 countries. Key export markets include India, New Zealand, the UK, the US and most of Europe. With interest skyrocketing, Better Breathing Sport is expecting a substantial increase in export sales over the next two years.
Visit Better Breathing Sport website.
Linear Clinical Research bridges the gap between the laboratory bench and the bedside. The company delivers early-phase clinical trials across a wide range of therapeutic areas. These trials are critical in the development of new therapies and medications.
Linear Clinical Research is responsible for recruiting patients, dosing patients, and ensuring new and innovative therapies are safe and well tolerated. Its clients are mainly biotechnology and pharmaceutical companies from 16 countries. Key export markets include China, Denmark, France, Japan, Korea, Singapore, Sweden, Switzerland, Taiwan, the UK and the US. Export revenue made up 87.5% of total revenue in 2022.
Visit Linear Clinical Research website.
Brisbane-based Qlicksmart specialises in safety medical devices. For more than 20 years, its products have improved staff and patient safety worldwide.
Qlicksmart’s flagship device range is the world’s first single-handed scalpel blade remover. These devices ensure users stay safe and comply with infection control and workplace regulations. Exports of their sterile range have increased 45% since last financial year.
Qlicksmart’s safety devices are used in over 50 countries. They are supplied through a network of 120 distribution partners. Key export markets include Canada, Germany, Hong Kong, Japan, the Netherlands, New Zealand, the UK and the US.
Visit Qlicksmart website.
SDI products help dentists provide easier, faster and longer lasting smiles for patients across the globe. It is a world leader in specialist dental materials including tooth fillings and tooth whitening products. SDI strives to improve oral health by continuously developing products that subscribe to the notion of minimal intervention dentistry.
SDI products are sold to dentists in over 100 countries. Key export markets include Brazil, Germany, Korea, Poland, Saudi Arabia, Spain, the UK, Canada and the US. Ninety per cent of all SDI sales are to overseas markets. In addition to its head office in Australia, SDI has fully owned subsidiaries in Brazil, Germany and the US.
Visit SDI website.